TASMAR Side Effects

6309969-1 | Nervous System Disorder, Respiratory Arrest
on Jul 29, 2009 Female patient from GERMANY , 72 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). Patient experienced the following unwanted or unexpected effects: nervous system disorder, respiratory arrest. Tasmar dosage: . Patient was hospitalized.

6301902-1 | Respiratory Arrest
Patient was taking Tasmar (View Usage). Patient had the following side effects: respiratory arrest on Jul 29, 2009 from GERMANY Additional patient health information: Female patient , 72 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Tasmar dosage: . Patient was hospitalized.

6293323-5 | Dyskinesia, Hepatic Function Abnormal, Rhabdomyolysis
Adverse event was reported on Jul 29, 2009 by a Female patient taking Tasmar (View Usage) (Dosage: ) . Location: ITALY , 60 years of age, After Tasmar was administered, patient had the following side effects: dyskinesia, hepatic function abnormal, rhabdomyolysis. During the same period patient was treated with SINEMET (Dose Unit:) (View Sinemet Review and Sinemet Label ), ARTANE (View Artane Review and Artane Label ), XANAX (View Xanax Review and Xanax Label ), TRITTICO (View Trittico Review and Trittico Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), MIRAPEX (View Mirapex Review and Mirapex Label ).

6175962-5 | Diarrhoea, Intentional Overdose, Suicide Attempt
on Apr 21, 2009 Female patient from GERMANY , 53 years of age, was treated with Tasmar (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, intentional overdose, suicide attempt. Tasmar dosage: . Patient was hospitalized.


6011506-6 | Asthma, Hypotension, Loss Of Consciousness
on May 22, 1998 Male patient from UNITED STATES , weighting 185.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), asthma (What is asthma?) and was treated with Tasmar (View Usage). Patient had the following side effects: asthma (What is asthma?), hypotension, loss of consciousness. Tasmar dosage: . During the same period patient was treated with REQUIP (View Requip Review and Requip Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ZAFIRLUKAST (View Zafirlukast Review and Zafirlukast Label ), STEROID (View Steroid Review and Steroid Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), ST JOHN'S WORT (View St John's Wort Review and St John's Wort Label ).

5745521-4 | Colitis Ischaemic, Peritonitis, Sepsis
Patient was taking Tasmar (View Usage). After Tasmar was administered, patient had the following side effects: colitis ischaemic, peritonitis, sepsis (What is sepsis?) on May 09, 2008 from SLOVENIA Additional patient health information: Male patient , 77 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Tasmar dosage: . During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), LYRICA (View Lyrica Review and Lyrica Label ), AZILECT (View Azilect Review and Azilect Label ). Patient was hospitalized.

5734525-3 | Chest Discomfort, Clostridial Infection, Effusion, Pneumonia, Pneumothorax, Staphylococcal Infection
Adverse event was reported on May 08, 2008 by a Male patient taking Tasmar (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED KINGDOM , 67 years of age, Patient experienced the following unwanted or unexpected effects: chest discomfort, clostridial infection, effusion, pneumonia (What is pneumonia?), pneumothorax, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), BROMOCRIPTINE MESYLATE (20 Mg, Qid) (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ). Patient was hospitalized.

5699095-7 | Diarrhoea
on Aug 09, 2007 Female patient from UNITED STATES , 67 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). Patient had the following side effects: diarrhoea. Tasmar dosage: 100 Mg;tid;po ; 200 Mg;tid;po ; 100 Mg;bid;po. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

5671426-3 | Blood Albumin Decreased, Blood Creatinine Increased, Blood Urea Increased, Dyspnoea, Hallucination, Oedema Peripheral
on Mar 03, 2008 Male patient from CANADA , 90 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). After Tasmar was administered, patient had the following side effects: blood albumin decreased, blood creatinine increased, blood urea increased, dyspnoea, hallucination, oedema peripheral. Tasmar dosage: 300 Mg; Qd; Po. During the same period patient was treated with SINEMET CR (View Sinemet Cr Review and Sinemet Cr Label ), BROMOCRIPTINE MESYLATE (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ), DOCUSATE (View Docusate Review and Docusate Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ). Patient was hospitalized.

5670097-X | Antinuclear Antibody Positive, Biliary Cirrhosis, Blood Fibrinogen Decreased, Blood Glucose Increased, Blood Iron Increased, Depressed Level Of Consciousness, Diarrhoea, Dilatation Atrial, Gallbladder Disorder
Patient was taking Tasmar (View Usage). Patient experienced the following unwanted or unexpected effects: antinuclear antibody positive, biliary cirrhosis, blood fibrinogen decreased, blood glucose increased, blood iron increased, depressed level of consciousness, diarrhoea, dilatation atrial, gallbladder disorder on Feb 29, 2008 from CANADA Additional patient health information: Female patient , 74 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Tasmar dosage: 100 Mg; Tid; Po; 50 Mg; Tid; Po. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TYLENOL NO.2 (View Tylenol No.2 Review and Tylenol No.2 Label ), ARTANE (View Artane Review and Artane Label ), PROVERA (View Provera Review and Provera Label ), PERMAX (View Permax Review and Permax Label ), PREMARIN (View Premarin Review and Premarin Label ), ASPIRIN 10GR TIMED DISINTEGRATION TAB (View Aspirin 10gr Timed Disintegration Tab Review and Aspirin 10gr Timed Disintegration Tab Label ).

5670036-1 | Metastases To Liver, Respiratory Distress, Septic Shock
Adverse event was reported on Feb 29, 2008 by a Female patient taking Tasmar (View Usage) (Dosage: 100 Mg;tid;po) . Location: CANADA , 59 years of age, Patient had the following side effects: metastases to liver, respiratory distress, septic shock. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ). Patient was hospitalized.

5578581-4 | Alanine Aminotransferase Increased
on Mar 07, 2007 Female patient from UNITED KINGDOM , 70 years of age, weighting 154.1 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). After Tasmar was administered, patient had the following side effects: alanine aminotransferase increased. Tasmar dosage: 100 Mg; Tid. During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), CLEXANE (View Clexane Review and Clexane Label ).

5517881-0 | Activities Of Daily Living Impaired, Agitation, Crying, Depression, Disorientation, Dysarthria, Fall, Hallucination
on Oct 26, 2007 Male patient from UNITED STATES , 85 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, agitation, crying, depression (What is depression?), disorientation, dysarthria, fall (What is fall?), hallucination. Tasmar dosage: Tid;po. During the same period patient was treated with LEVODOPA CARBIDOPA IR (View Levodopa-carbidopa Ir Review and Levodopa-carbidopa Ir Label ), MIRAPEX (View Mirapex Review and Mirapex Label ), COZAAR (View Cozaar Review and Cozaar Label ), ISORDIL (View Isordil Review and Isordil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), XALATAN (View Xalatan Review and Xalatan Label ), LEVODOPA CARBIDOPA CR (View Levodopa-carbidopa Cr Review and Levodopa-carbidopa Cr Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ).

5454995-8 | Parkinsonism, Rash Erythematous
Patient was taking Tasmar (View Usage). Patient had the following side effects: parkinsonism, rash erythematous on Aug 30, 2007 from FRANCE Additional patient health information: Female patient , 47 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Tasmar dosage: Tid. During the same period patient was treated with MADOPAR (MADOPAR) (View Madopar (madopar) Review and Madopar (madopar) Label ), COZAAR (View Cozaar Review and Cozaar Label ). Patient was hospitalized.

5449588-2 | Pulmonary Oedema
Adverse event was reported on May 11, 2006 by a Male patient taking Tasmar (View Usage) (Dosage: 200 Mg; Tid; Po) . Location: CANADA , 58 years of age, After Tasmar was administered, patient had the following side effects: pulmonary oedema. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), BROMOCRIPTINE MESYLATE (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ).

5449587-0 | Pneumonia
on May 11, 2006 Male patient from CANADA , 81 years of age, was treated with Tasmar (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Tasmar dosage: 100 Mg; Tid; Po.

5449586-9 | Cerebrovascular Accident
on May 11, 2006 Female patient from CANADA , 82 years of age, was treated with Tasmar (View Usage). Patient had the following side effects: cerebrovascular accident. Tasmar dosage: 100 Mg; Tid; Po.

5449584-5 | Antinuclear Antibody Positive, Biliary Cirrhosis, Blood Fibrinogen Decreased, Blood Glucose Increased, Blood Iron Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Depressed Level Of Consciousness, Diarrhoea
Patient was taking Tasmar (View Usage). After Tasmar was administered, patient had the following side effects: antinuclear antibody positive, biliary cirrhosis, blood fibrinogen decreased, blood glucose increased, blood iron increased, blood lactate dehydrogenase increased, blood urea increased, depressed level of consciousness, diarrhoea on May 11, 2006 from CANADA Additional patient health information: Female patient , 74 years of age, . Tasmar dosage: 300 Mg; Qd; Po. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TYLENOL NO. 2 (View Tylenol No. 2 Review and Tylenol No. 2 Label ), ARTANE (View Artane Review and Artane Label ), PROVERA (View Provera Review and Provera Label ), PERMAX (View Permax Review and Permax Label ), PREMARIN (View Premarin Review and Premarin Label ), ASPIRIN 10GR TIMED DISINTEGRATION TAB (View Aspirin 10gr Timed Disintegration Tab Review and Aspirin 10gr Timed Disintegration Tab Label ), SINEMET (View Sinemet Review and Sinemet Label ).

5449583-3 | Respiratory Distress
Adverse event was reported on May 11, 2006 by a Female patient taking Tasmar (View Usage) (Dosage: 100 Mg; Tid; Po) . Location: CANADA , 59 years of age, Patient experienced the following unwanted or unexpected effects: respiratory distress. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ).

5419753-9 | Condition Aggravated, Contusion, Fall, Hepatic Failure, Parkinson's Disease
on May 15, 2007 Female patient from UNITED KINGDOM , 68 years of age, weighting 117.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). Patient had the following side effects: condition aggravated, contusion, fall (What is fall?), hepatic failure, parkinson's disease (What is parkinson's disease?). Tasmar dosage: 100 Mg; Tid; Po; 100 Mg; Qd; Po. During the same period patient was treated with L DOPA (View L-dopa Review and L-dopa Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), CARBIDOPA (View Carbidopa Review and Carbidopa Label ), CO CARELDOPA (View Co-careldopa Review and Co-careldopa Label ).

5329748-1 | Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Liver Function Test Abnormal
on Apr 30, 2007 Female patient from CANADA , 75 years of age, weighting 114.6 lb, was treated with Tasmar (View Usage). After Tasmar was administered, patient had the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver function test abnormal. Tasmar dosage: 10 Mg; Tid; Po. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), PERMAX (View Permax Review and Permax Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), EXELON (View Exelon Review and Exelon Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), TYLENOL W/ CODEINE NO. 3 (View Tylenol W/ Codeine No. 3 Review and Tylenol W/ Codeine No. 3 Label ), AMOXICLAV (View Amoxiclav Review and Amoxiclav Label ).

5306612-5 | Anaemia, Compartment Syndrome, Condition Aggravated, Deep Vein Thrombosis, Haemorrhage, Hepatic Failure, International Normalised Ratio Increased, Multi-organ Failure, Myocardial Infarction
Patient was taking Tasmar (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, compartment syndrome, condition aggravated, deep vein thrombosis (What is deep vein thrombosis?), haemorrhage, hepatic failure, international normalised ratio increased, multi-organ failure, myocardial infarction on Apr 03, 2007 from GERMANY Additional patient health information: Male patient , 80 years of age, weighting 138.9 lb, was diagnosed with parkinsonism and. Tasmar dosage: 100 Mg;tid; Po. During the same period patient was treated with ISOCOM (View Isocom Review and Isocom Label ), SIFROL (View Sifrol Review and Sifrol Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), PK MERZ (View Pk-merz Review and Pk-merz Label ), CARBIDOPA (View Carbidopa Review and Carbidopa Label ). Patient was hospitalized.

5295740-9 | Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease
Adverse event was reported on Mar 30, 2007 by a Male patient taking Tasmar (View Usage) (Dosage: See Image) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED KINGDOM , 68 years of age, weighting 240.3 lb, Patient had the following side effects: cardiac failure congestive, chronic obstructive pulmonary disease. During the same period patient was treated with MADOPAR (MADOPAR) (1000 Mg; Qd;) (View Madopar (madopar) Review and Madopar (madopar) Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ENTACAPONE (View Entacapone Review and Entacapone Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), RASAGILINE MESILATE (View Rasagiline Mesilate Review and Rasagiline Mesilate Label ).

5291405-8 | Acute Hepatic Failure, Anaemia, Blood Creatine Phosphokinase Increased, Cardiovascular Disorder, Coagulopathy, Compartment Syndrome, Deep Vein Thrombosis, Factor V Leiden Mutation, Multi-organ Failure
on Mar 13, 2007 Male patient from GERMANY , 80 years of age, was diagnosed with parkinsonism and was treated with Tasmar (View Usage). After Tasmar was administered, patient had the following side effects: acute hepatic failure, anaemia, blood creatine phosphokinase increased, cardiovascular disorder, coagulopathy, compartment syndrome, deep vein thrombosis (What is deep vein thrombosis?), factor v leiden mutation, multi-organ failure. Tasmar dosage: . During the same period patient was treated with ISOCOM (View Isocom Review and Isocom Label ), SIFROL (View Sifrol Review and Sifrol Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), PK MERZ (View Pk-merz Review and Pk-merz Label ). Patient was hospitalized.

5281224-0 | Anaemia, Blood Creatine Phosphokinase Increased, Compartment Syndrome, Deep Vein Thrombosis, Hepatic Enzyme Increased, Multi-organ Failure, Myocardial Infarction
on Mar 06, 2007 Male patient from GERMANY , 80 years of age, was diagnosed with parkinsonism and was treated with Tasmar (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood creatine phosphokinase increased, compartment syndrome, deep vein thrombosis (What is deep vein thrombosis?), hepatic enzyme increased, multi-organ failure, myocardial infarction. Tasmar dosage: . During the same period patient was treated with ISOCOM (View Isocom Review and Isocom Label ), SIFROL (View Sifrol Review and Sifrol Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ). Patient was hospitalized.

5270422-8 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Fall, Hepatic Enzyme Increased, Influenza, Nausea, Parkinson's Disease
Patient was taking Tasmar (View Usage). Patient had the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, fall (What is fall?), hepatic enzyme increased, influenza, nausea (What is nausea?), parkinson's disease (What is parkinson's disease?) on Feb 26, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 68 years of age, weighting 117.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Tasmar dosage: 100 Mg; Tid; Po. During the same period patient was treated with L DOPA (View L-dopa Review and L-dopa Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), CARBIDOPA (View Carbidopa Review and Carbidopa Label ), CO CARELDOPA (View Co-careldopa Review and Co-careldopa Label ).

5255782-6 | Aggression, Agitation, Arrhythmia, Atrial Fibrillation, Cardiomegaly, Cerebral Atrophy, Dementia, Disturbance In Attention
Adverse event was reported on Dec 29, 2006 by a Female patient taking Tasmar (View Usage) (Dosage: See Image) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: GERMANY , 80 years of age, After Tasmar was administered, patient had the following side effects: aggression, agitation, arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), cardiomegaly, cerebral atrophy, dementia (What is dementia?), disturbance in attention. During the same period patient was treated with CANDESARTAN (View Candesartan Review and Candesartan Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CARBIDOPA (View Carbidopa Review and Carbidopa Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ).

5236717-9 | Alanine Aminotransferase Increased, Lung Neoplasm Malignant
on Aug 21, 2006 Female patient from UNITED KINGDOM , 70 years of age, weighting 154.1 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, lung neoplasm malignant. Tasmar dosage: 100 Mg, Tid;. During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), CLEXANE (View Clexane Review and Clexane Label ).

5236716-7 | Hepatitis
on Nov 02, 2006 Female patient from IRELAND , 61 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?). Tasmar dosage: 100 Mg, Po. During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), SINEMET CR (View Sinemet Cr Review and Sinemet Cr Label ).

5154553-9 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Condition Aggravated, Fall, Hepatic Enzyme Increased, Hepatic Failure, Influenza, Malaise, Parkinson's Disease
Patient was taking Tasmar (View Usage). After Tasmar was administered, patient had the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, condition aggravated, fall (What is fall?), hepatic enzyme increased, hepatic failure, influenza, malaise, parkinson's disease (What is parkinson's disease?) on Oct 30, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 68 years of age, weighting 117.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Tasmar dosage: 100 Mg Tid Po. During the same period patient was treated with L DOPA (View L-dopa Review and L-dopa Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), CARBIDOPA (View Carbidopa Review and Carbidopa Label ).

5103001-3 | Alanine Aminotransferase Increased
Adverse event was reported on Aug 25, 2006 by a Male patient taking Tasmar (View Usage) (Dosage: 100 Mg; Tid; Po) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED KINGDOM , 65 years of age, weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased. During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), APOMORPHINE (View Apomorphine Review and Apomorphine Label ), SALICYLIC ACID (View Salicylic Acid Review and Salicylic Acid Label ), ENTACAPONE (View Entacapone Review and Entacapone Label ).

5085783-2 | Hepatic Failure
on Aug 01, 2006 Female patient from UNITED KINGDOM , 68 years of age, weighting 117.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). Patient had the following side effects: hepatic failure. Tasmar dosage: 100 Mg; Tid; Po. During the same period patient was treated with L DOPA (View L-dopa Review and L-dopa Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), CARBIDOPA (View Carbidopa Review and Carbidopa Label ).

5072947-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased
on Jul 21, 2006 Male patient from UNITED KINGDOM , 65 years of age, weighting 138.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). After Tasmar was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased. Tasmar dosage: 300 Mg; Qd; Po. During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), APOMORPHINE (View Apomorphine Review and Apomorphine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MADOPAR (View Madopar Review and Madopar Label ).

5050662-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased
Patient was taking Tasmar (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased on Jun 26, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 65 years of age, weighting 138.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Tasmar dosage: 300 Mg;qd;po. During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), APOMORPHINE (View Apomorphine Review and Apomorphine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MADOPAR (View Madopar Review and Madopar Label ).

5046553-4 | Gastrointestinal Carcinoma, Malignant Neoplasm Progression, Metastases To Liver
Adverse event was reported on Jun 20, 2006 by a Male patient taking Tasmar (View Usage) (Dosage: Po) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: NEW ZEALAND , 63 years of age, Patient had the following side effects: gastrointestinal carcinoma, malignant neoplasm progression, metastases to liver. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), BENSERAZIDE (View Benserazide Review and Benserazide Label ), CARBIODPA (View Carbiodpa Review and Carbiodpa Label ).

4838065-5 | Acute Myocardial Infarction, Blood Pressure Decreased, Cardiac Failure Acute, Haemoglobin Decreased, Hepatic Enzyme Increased, Hyperhidrosis, Liver Disorder, Lung Disorder, Metabolic Acidosis
on Feb 18, 2004 Male patient from SWITZERLAND , 61 years of age, weighting 159.8 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), sedation, anaesthesia, intubation, mean arterial pressure and was treated with Tasmar (View Usage). After Tasmar was administered, patient had the following side effects: acute myocardial infarction, blood pressure decreased, cardiac failure acute, haemoglobin decreased, hepatic enzyme increased, hyperhidrosis, liver disorder, lung disorder, metabolic acidosis. Tasmar dosage: . During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), PANCURONIUM (View Pancuronium Review and Pancuronium Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

4804906-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on Sep 16, 2005 Female patient from SWITZERLAND , 59 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased. Tasmar dosage: 100 Mg; 3 Times A Day;. During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), PERIBEDIL (View Peribedil Review and Peribedil Label ), SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

4788292-0 | Alanine Aminotransferase Increased
Patient was taking Tasmar (View Usage). Patient had the following side effects: alanine aminotransferase increased on Sep 16, 2005 from RUSSIAN FEDERATION Additional patient health information: Female patient , 59 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Tasmar dosage: 100 Mg; 3 Times A Day. During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), PERIBEDIL (View Peribedil Review and Peribedil Label ), COAXIL (View Coaxil Review and Coaxil Label ), CIPRAMIL (View Cipramil Review and Cipramil Label ).

4788291-9 | Alanine Aminotransferase Increased
Adverse event was reported on Sep 16, 2005 by a Female patient taking Tasmar (View Usage) (Dosage: 100 Mg; 3 Times A Day) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: RUSSIAN FEDERATION , 59 years of age, After Tasmar was administered, patient had the following side effects: alanine aminotransferase increased. During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), PERIBEDIL (View Peribedil Review and Peribedil Label ), SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

4701355-0 | Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased
on Jun 16, 2005 Female patient from , 67 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased. Tasmar dosage: 100 Mg; 3 Times A Day; Oral. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), MADOPAR QUICK (View Madopar Quick Review and Madopar Quick Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FOROSEMID (View Forosemid Review and Forosemid Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ).

4701351-3 | Dyspnoea Exertional, Fatigue, Fibrosis, Pleural Fibrosis, Pulmonary Fibrosis, Weight Decreased
on Jun 14, 2005 Male patient from , 66 years of age, was diagnosed with parkinsonism and was treated with Tasmar (View Usage). Patient had the following side effects: dyspnoea exertional, fatigue, fibrosis, pleural fibrosis, pulmonary fibrosis (What is pulmonary fibrosis?), weight decreased. Tasmar dosage: Oral. During the same period patient was treated with MADOPARK (LEVODOPA/BENSERAZIDE HYDROCHLORIDE) (Oral) (View Madopark (levodopa/benserazide Hydrochloride) Review and Madopark (levodopa/benserazide Hydrochloride) Label ), MADOPARK QUICK (LEVODOPA/BENSERAZIDE HYDROCHLORIDE) (Oral) (View Madopark Quick (levodopa/benserazide Hydrochloride) Review and Madopark Quick (levodopa/benserazide Hydrochloride) Label ), SIFROL (PRAMIPEXOLE DIHYDROCHLORIDE) (1.1 MG) (Oral) (View Sifrol (pramipexole Dihydrochloride) (1.1 Mg) Review and Sifrol (pramipexole Dihydrochloride) (1.1 Mg) Label ), ORSTANORM (DIHYDROERGOTAMINE MESILATE) (5 MG) (5 Mg; Oral) (View Orstanorm (dihydroergotamine Mesilate) (5 Mg) Review and Orstanorm (dihydroergotamine Mesilate) (5 Mg) Label ), EFFEXOR (View Effexor Review and Effexor Label ), HYOSCYAMINE SULFATE (View Hyoscyamine Sulfate Review and Hyoscyamine Sulfate Label ), BETOLVEX (View Betolvex Review and Betolvex Label ), CLARITIN (View Claritin Review and Claritin Label ). Patient was hospitalized.

4676532-8 | Confusional State, Hepatitis, Hepatotoxicity, Jaundice, Rhabdomyolysis
Patient was taking Tasmar (View Usage). After Tasmar was administered, patient had the following side effects: confusional state, hepatitis (What is hepatitis?), hepatotoxicity, jaundice (What is jaundice?), rhabdomyolysis on May 13, 2005 from Additional patient health information: Male patient , 60 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Tasmar dosage: . During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), PERGOLIDE MESYLATE (View Pergolide Mesylate Review and Pergolide Mesylate Label ).

4639099-6 | Aortic Valve Sclerosis, Bronchitis Acute, Hepatic Enzyme Increased
Adverse event was reported on Apr 08, 2005 by a Male patient taking Tasmar (View Usage) (Dosage: 100 Mg; 3 Times A Day; Oral; See Image) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: , 60 years of age, Patient experienced the following unwanted or unexpected effects: aortic valve sclerosis, bronchitis acute, hepatic enzyme increased. During the same period patient was treated with PERGOLIDE MESYLATE (4.5 Gm) (View Pergolide Mesylate Review and Pergolide Mesylate Label ), CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), AMANTADINE SULFATE (View Amantadine Sulfate Review and Amantadine Sulfate Label ), COMTESS (View Comtess Review and Comtess Label ), NACOM SLOW RELEASE (View Nacom - Slow Release Review and Nacom - Slow Release Label ). Patient was hospitalized.

4621109-3 | Aortic Valve Sclerosis, Hepatic Enzyme Increased
on Feb 15, 2005 Male patient from , 60 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). Patient had the following side effects: aortic valve sclerosis, hepatic enzyme increased. Tasmar dosage: 100 Mg; 3 Times A Day; Oral. During the same period patient was treated with PERGOLIDE MESYLATE (4.5 Gm) (View Pergolide Mesylate Review and Pergolide Mesylate Label ), CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), AMANTADINE DULFATE (View Amantadine Dulfate Review and Amantadine Dulfate Label ), NACOM SLOW RELEASE (100 Mg; 3 Times A Day; Oral) (View Nacom-slow Release Review and Nacom-slow Release Label ), AMANTADINE SULFATE (View Amantadine Sulfate Review and Amantadine Sulfate Label ), COMITESS (View Comitess Review and Comitess Label ). Patient was hospitalized.

4613250-6 | Hypoaesthesia
on Feb 28, 2005 Female patient from , 61 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Tasmar (View Usage). After Tasmar was administered, patient had the following side effects: hypoaesthesia. Tasmar dosage: 300 Mg; Daily; Oral. During the same period patient was treated with MADOPAR CR (LEVODOPA/BENSERAZIDE HYDROCHLORIDE) (125 MG) (125 Mg; Daily; Oral) (View Madopar Cr (levodopa/benserazide Hydrochloride) (125 Mg) Review and Madopar Cr (levodopa/benserazide Hydrochloride) (125 Mg) Label ), MADOPAR (LEVODOPA/BENSERAZIDE HYDROCHLORIDE) (250 MG) (750 Mg; Daily; Oral) (View Madopar (levodopa/benserazide Hydrochloride) (250 Mg) Review and Madopar (levodopa/benserazide Hydrochloride) (250 Mg) Label ), MIRAPEXIN (PRAMIPEXOLE DIHYDROCHLORIDE) (0.75 MG) (2.25 Mg;daily) (View Mirapexin (pramipexole Dihydrochloride) (0.75 Mg) Review and Mirapexin (pramipexole Dihydrochloride) (0.75 Mg) Label ), PLURIMEN (SELEGILINE HYDROCHLORIDE) (5 MG) (10 Mg; Daily; Oral) (View Plurimen (selegiline Hydrochloride) (5 Mg) Review and Plurimen (selegiline Hydrochloride) (5 Mg) Label ).